Jpmorgan Chase & CO Sema4 Holdings Corp. Transaction History

Jpmorgan Chase & CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 18, 2023	BUY	$0.24 - $0.52 $54,398 - $117,863	226,660 Added 20775.44%	227,751 $77,000
Q1 2023 May 11, 2023	SELL	$0.24 - $0.52 $26,527 - $57,475	-110,530 Reduced 99.02%	1,091 $0
Q4 2022 Feb 13, 2023	SELL	$0.22 - $1.04 $16,743 - $79,152	-76,108 Reduced 40.54%	111,621 $29,000
Q3 2022 Nov 14, 2022	BUY	$0.25 - $2.4 $1,085 - $10,423	4,343 Added 2.37%	187,729 $165,000
Q2 2022 Aug 11, 2022	BUY	$1.22 - $3.05 $179,757 - $449,393	147,342 Added 408.78%	183,386 $232,000
Q1 2022 May 11, 2022	BUY	$2.64 - $4.67 $9,760 - $17,264	3,697 Added 11.43%	36,044 $111,000
Q4 2021 Feb 10, 2022	BUY	$4.4 - $8.8 $142,326 - $284,653	32,347 New	32,347 $144,000

166K

Ticker SMFR
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 380,641,984
Market Cap $129M
Description
Sema4 Holdings Corp., doing business as Sema4, operates as a health information company that enhances diagnosis, treatment, and prevention of disease through data. The company provides Centrellis, an AI-driven health intelligence platform that delivers comprehensive insights to biopharma to accelerate the drug discovery, development, and commerc...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.